Anti-COVID-19 Nucleocapsid Protein Antibody
2227.94 €
In Stock
quantity
product details
Catalog number: 544 - MBS8309654-1mL
Product Category: Business & Industrial > Science & Laboratory
Gentaur
Size: 1mL
DL99719A-100ul
E.coli anti-COVID-19 Nucleocapsid Protein scFv Antibody
Nucleoprotein; Nucleocapsid protein; NC; Protein N
604.49 €
DL99719A-50ul
E.coli anti-COVID-19 Nucleocapsid Protein scFv Antibody
Nucleoprotein; Nucleocapsid protein; NC; Protein N
469.65 €
9103-002mg
SARS-CoV-2 (COVID-19) Nucleocapsid Antibody
Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2). Nucleocapsid (N) protein is the most abundant protein of coronavirus. It is also one of the major structural proteins and is involved in the transcription and replication of viral RNA, packaging of the encapsidated genome into virions (3), and interference with cell cycle processes of host cells (4). Moreover, in many coronaviruses, including SARS-CoV, the N protein has high immunogenic activity and is abundantly expressed during infection (5). It can be detected in various patient samples including nasopharyngeal aspirate, urine, and fecal. Both S and N proteins may be potential antigens for serodiagnosis of COVID-19, just as many diagnostic methods have been developed for diagnosing SARS based on S and/or N proteins (6).